Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
Location: United States, Massachusetts, Boston
Employees: 51-200
Total raised: $270M
Founded date: 2020
Investors 7
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.01.2021 | Series B | $162M | - |
| 29.10.2020 | - | $108M | Vida Ventu... |
Mentions in press and media 19
| Date | Title | Description | Source |
| 10.10.2023 | Scorpion Therapeutics and Pierre Fabre Laboratories Announce... | -- STX-721 is characterized by high selectivity and a potentially best-in-class profile -- -- Scorp... | en.prnasia... |
| 08.01.2021 | Armed with $270M in capital, Scorpion Therapeutics aims to b... | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems st... | medcitynew... |
| 08.01.2021 | Daily funding roundup - January 8th, 2021 | SilviaTerra raised $4.4M; Hipcamp landed $57M; DiCE Molecules secured $80M; Affinivax picks up $226M... | vator.tv/n... |
| 07.01.2021 | Congratulations Gary Glick, CEO and the Scorpion Therapeutic... | - | abingworth... |
| 07.01.2021 | Scorpion Therapeutics Announces Oversubscribed $162 Million ... | Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the closi... | marketscre... |
| 07.01.2021 | Three months after launch, precision medicine startup Scorpi... | Less than three months after publicly launching, Scorpion Therapeutics, a cancer-focused precision m... | bizjournal... |
| 07.01.2021 | Scorpion Therapeutics strikes major $162M funding round for ... | Less than three months after breaking cover with an impressive $102 million series A, Scorpion has w... | fiercebiot... |
| 07.01.2021 | Scorpion Therapeutics Announces Oversubscribed $162 Million ... | - | vidaventur... |
| 07.01.2021 | Scorpion Therapeutics, Inc. announced that it has received $... | On January 7, 2021, Scorpion Therapeutics, Inc. closed the transaction. The company has received $15... | marketscre... |
| 07.01.2021 | Scorpion Therapeutics Raises $162M In Series B | BOSTON--(BUSINESS WIRE)--Scorpion Therapeutics, Inc., a next-generation precision oncology company, ... | citybizlis... |
Show more